Cencora : CDP Climate Change Disclosure

About this update from Cencora, Inc.

Cencora, Inc. 2025 CDP Corporate Questionnaire 2025 12/18/2025, 03:09 pm C1. Introduction (1.2) Select the currency used for all financial information disclosed throughout your response. Select from: ☑ USD (1.3) Provide an overview and introduction to your organization. (1.3.2) Organization type Select from: ☑ Publicly traded organization (1.3.3) Description of organization Cencora is a leading global pharmaceutical solutions company centered on improving the lives of people and animals around the world by advancing the development of and access to pharmaceuticals and healthcare products. Cencora is headquartered in Conshohocken, Pennsylvania, and as of FY24, employs 46,000+ people around the world. Cencora is ranked #10 on the Fortune 500 list and #24 on the Global Fortune 500 list, with over 290 billion in annual revenue in FY24. Cencora effectively and safely delivers life-changing medicines from manufacturing partners directly toto a wide variety of healthcare providers - from small, rural pharmacies and specialty physicians to large hospital systems and the world's largest retail chains - across the United States and select global markets. As an expert in pharmaceutical distribution and services, we also provide innovative solutions to partners across the health care landscape, striving to ensure safety, efficiency and enhanced patient access and affordability. As a pharmaceutical distributor, we efficiently supply hundreds of thousands of sites of care with life-saving medications every day - enhancing public health infrastructure and improving health outcomes. We drive success and growth for providers and manufacturers, freeing more of their time and resources for what they do best - developing innovative therapies and delivering care. At Cencora, we recognize that the economic, social, and physical environments in which our company operates are integral to our ability to deliver better patient outcomes. Our purpose becomes increasingly evident in the event of climate-related issues such as severe weather events or natural disasters. Our commitment to environmental sustainability and social impact focuses on three core areas: purpose-driven team members, resilient and sustainable operations, and healthy customers and communities. Resilient operations are critical to meeting environmental challenges, such as natural disasters and a changing climate, and we are committed to responsible operations that contribute to a healthier planet. In December 2022, our near-term Science Based Target was approved by the Science Based Target Initiative (SBTi). Cencora commits to reduce absolute scope 1 and 2 GHG emissions 54.6% by FY2032 from a FY2019 base year. Cencora also commits that 82% of its suppliers by spend, covering purchased goods and services, will have science-based targets by FY2027. Further information is available at cencora.com. [Fixed row] (1.4) State the end date of the year for which you are reporting data. For emissions data, indicate whether you will be providing emissions data for past reporting years. (1.4.1) End date of reporting year 09/30/2024 (1.4.2) Alignment of this reporting period with your financial reporting period Select from: ☑ Yes (1.4.3) Indicate if you are providing emissions data for past reporting years Select from: ☑ Yes (1.4.4) Number of past reporting years you will be providing Scope 1 emissions data for Select from: ☑ 1 year (1.4.5) Number of past reporting years you will be providing Scope 2 emissions data for Select from: ☑ 1 year (1.4.6) Number of past reporting years you will be providing Scope 3 emissions data for Select from: ☑ Not providing past emissions data for Scope 3 [Fixed row] (1.4.1) What is your organization's annual revenue for the reporting period? 294000000000 (1.5) Provide details on your reporting boundary. Is your reporting boundary for your CDP disclosure the same as that used in your financial statements? Select from: ☑ Yes [Fixed row] (1.6) Does your organization have an ISIN code or another unique identifier (e.g., Ticker, CUSIP, etc.)? ISIN code - bond (1.6.1) Does your organization use this unique identifier? Select from: ☑ No ISIN code - equity (1.6.1) Does your organization use this unique identifier? Select from: ☑ Yes (1.6.2) Provide your unique identifier US03073E1055 CUSIP number (1.6.1) Does your organization use this unique identifier? Select from: ☑ Yes (1.6.2) Provide your unique identifier 03073E 10 5 Ticker symbol (1.6.1) Does your organization use this unique identifier? Select from: ☑ Yes (1.6.2) Provide your unique identifier COR SEDOL code (1.6.1) Does your organization use this unique identifier? Select from: ☑ Yes (1.6.2) Provide your unique identifier 2795393 LEI number

View stock analysis, news, and events for Cencora, Inc.